PC(18:2(9Z,12Z)/20:3(8Z,11Z,14Z))

Term ID

CHEBI:89580

Synonyms

(2-{[(2R)-2-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyloxy]-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium
1-Linoleoyl-2-homo-g-linolenoyl-sn-glycero-3-phosphocholine
1-Linoleoyl-2-homo-gamma-linolenoyl-sn-glycero-3-phosphocholine
GPCho(18:2/20:3)
GPCho(18:2n6/20:3n6)
GPCho(18:2w6/20:3w6)
GPCho(38:5)
Lecithin
PC aa C38:5
PC(18:2/20:3)
PC(18:2n6/20:3n6)
PC(18:2w6/20:3w6)
PC(38:5)
Phosphatidylcholine(18:2/20:3)
Phosphatidylcholine(18:2n6/20:3n6)
Phosphatidylcholine(18:2w6/20:3w6)
Phosphatidylcholine(38:5)

(all 17)

Definition

References

(all 4)

Ontology

ChEBI ( EBI )

Relationships

is a type of: 1,2-diacyl-sn-glycero-3-phosphocholine

1,2-diacyl-sn-glycero-3-phosphocholine Show first 5 Terms

Phenotype

Phenotype resulting from PC(18:2(9Z,12Z)/20:3(8Z,11Z,14Z))

Phenotype where environments contain PC(18:2(9Z,12Z)/20:3(8Z,11Z,14Z))

Phenotype modified by environments containing PC(18:2(9Z,12Z)/20:3(8Z,11Z,14Z))

Phenotype affecting PC(18:2(9Z,12Z)/20:3(8Z,11Z,14Z))

Human Disease Model